| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | +3270.2% | +1274.4% |
| Cost of Revenue | $1.5M | +6927.8% | +268.0% |
| Gross Profit | $543K | +2174.7% | +285.9% |
| R&D Expense | $9K | +33.0% | -16.0% |
| SG&A Expense | $17.2M | +294.5% | +51.7% |
| Interest Expense | $133K | +14.9% | — |
| Net Income | -$33.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $55K | +0.0% | +0.0% |
| Accounts Receivable | $358K | +197.8% | +6743.6% |
| Inventory | $891K | +5.9% | +70.1% |
| Current Assets | $58.5M | +166.6% | +1582.7% |
| Total Assets | $81.0M | +92.6% | +867.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Investing Cash Flow | $6.3M | — | — |
| Financing Cash Flow | $21.4M | — | — |
| -351.1% |
| -181.5% |
| EPS (Basic) | -$0.22 | -237.5% | -4.8% |
| $5.5M |
| -70.8% |
| +202.2% |
| Total Liabilities | $5.5M | -70.9% | +176.5% |
| Stockholders' Equity | $75.5M | +227.1% | +1084.0% |